Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
38.31
+2.83 (7.98%)
At close: Mar 9, 2026, 4:00 PM EDT
38.31
0.00 (0.00%)
After-hours: Mar 9, 2026, 4:02 PM EDT
Stoke Therapeutics Market Cap
Stoke Therapeutics has a market cap or net worth of $2.19 billion as of March 9, 2026. Its market cap has increased by 372.67% in one year.
Market Cap
2.19B
Enterprise Value
1.86B
1-Year Change
372.67%
Ranking
Category
Stock Price
$38.31
Market Cap Chart
Since June 19, 2019, Stoke Therapeutics's market cap has increased from $804.46M to $2.19B, an increase of 172.00%. That is a compound annual growth rate of 16.06%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 2.15B |
| Ascentage Pharma Group International | 2.13B |
| Iovance Biotherapeutics | 2.11B |
| Mineralys Therapeutics | 2.10B |
| Mesoblast | 2.08B |
| Ultragenyx Pharmaceutical | 2.05B |
| Soleno Therapeutics | 2.05B |
| Nektar Therapeutics | 1.98B |